written on 14.01.2021

China Biopharma Dealmaking 2020 Review

While many parts of the world ground to a halt as they tried to deal with the global pandemic, China had more or less brought the situation under control by June, and the healthcare deals engine just kept on churning. MSQ Ventures recently published its 2020 China Biopharma Global Transactions and IPOs Review report, some of the most striking highlights of which are featured below.

 

2020 In-Licensing Deals Overview

(Excluding JVs and co-development/co-marketing agreements)

Made with Visme Infographic Maker

 

Made with Visme Infographic Maker

 

Made with Visme Infographic Maker

 

Made with Visme Infographic Maker

 

2020 Out-Licensing Deals Overview

(Excluding JVs and co-development/co-marketing agreements)

Made with Visme Infographic Maker

Made with Visme Infographic Maker

Made with Visme Infographic Maker

 

Made with Visme Infographic Maker

 

Made with Visme Infographic Maker

 

 

Made with Visme Infographic Maker

Similar Facts and Figures

Latest Report